BRCA 1 & 2 Full Gene Sequencing
In India, 1 in 28 women will develop breast cancer — and BRCA gene mutations can raise that lifetime risk to 72%. This advanced Next-Generation Sequencing (NGS) test performs complete sequencing of both BRCA1 and BRCA2 genes, identifying all mutations that significantly increase risk of hereditary breast, ovarian, pancreatic, and prostate cancers. Early knowledge means early action — and potentially life-saving decisions for you and your family.
BRCA1 mutation status
Complete sequencing of BRCA1 gene — up to 72% lifetime breast cancer risk if mutated
BRCA2 mutation status
Complete sequencing of BRCA2 gene — increased risk for breast, ovarian, and pancreatic cancer
Family risk assessment
Whether mutations may be passed to children — guiding family testing decisions
Treatment guidance
BRCA status affects response to PARP inhibitors and targeted therapies for cancer treatment
Other cancer risks
Pancreatic, prostate, fallopian tube, and peritoneal cancer risk from BRCA mutations in men and women
Preventive action plan
Personalized screening schedule, preventive options, and surveillance recommendations
| Cancer Type | General Population Risk | BRCA1 Mutation Risk | BRCA2 Mutation Risk |
|---|---|---|---|
| Breast Cancer (Women) | ~12% | Up to 72% | Up to 69% |
| Ovarian Cancer | ~1–2% | Up to 44% | Up to 17% |
| Breast Cancer (Men) | <1% | ~1–2% | Up to 7% |
| Pancreatic Cancer | ~1% | Elevated | Up to 7% |
| Prostate Cancer (Men) | ~13% | Slightly elevated | Up to 27% |
Pre-test genetic counseling (recommended)
Speak with our Genomic Expert to understand what the test covers, what a positive or negative result means, and how it may affect you and your family. Strongly recommended before ordering.
Order with referral confirmation
Confirm you have a doctor's referral or have completed pre-test counseling. Your home collection kit ships within 24 hours.
Blood + Saliva sample collection
Collect both samples at home using your kit — blood via finger prick or collection tube, and saliva via cheek swab. Return using the prepaid courier label.
NGS Full Gene Analysis
Complete sequencing of both BRCA1 and BRCA2 genes performed in our NABL & CAP accredited lab using Next-Generation Sequencing technology.
Results + Genomic Expert Consultation
Detailed clinical report in 3–4 weeks. A Genomic Expert will contact you to review results, explain findings, and — if needed — connect you with an appropriate oncology specialist for next steps.
Your BRCA Gene Sequencing Report
A snapshot of your personalized clinical BRCA report
- Complete BRCA1 & BRCA2 full gene sequencing
- NGS technology — highest accuracy available
- Pathogenic variant + VUS classification
- Oncologist-ready clinical report
- NABL & CAP accredited lab
- Post-result Genomic Expert consultation